Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-year outcome

OBJECTIVE: To report the visual outcome after 4-year follow-up in a series of highly myopic eyes with choroidal neovascularisation (CNV) treated with antivascular endothelial growth factor (anti-VEGF) drugs. METHODS: A retrospective, non-randomised, multicentre, consecutive, interventional case seri...

ver descrição completa

Detalhes bibliográficos
Autor principal: Ruiz-Moreno, JM (author)
Outros Autores: Arias, L (author), Montero, JA (author), Carneiro, A (author), Silva, R (author)
Formato: article
Idioma:eng
Publicado em: 2014
Assuntos:
Anticorpos Monoclonais
Neovascularização da Coróide
Miopia Degenerativa
Texto completo:http://hdl.handle.net/10400.4/1677
País:Portugal
Oai:oai:rihuc.huc.min-saude.pt:10400.4/1677

Texto Completo

http://hdl.handle.net/10400.4/1677

Registos relacionados